ResMed, Google’s Verily ink sleep-apnea-focused joint venture deal

ResMed, Google’s Verily ink sleep-apnea-focused joint venture deal

Source: 
Mass Device
snippet: 

ResMed (NYSE:RMD) and Google (NSDQ:GOOG) life sciences company Verily said today they inked a new joint venture deal aiming to develop software solutions to improve diagnosis, treatment and care for sleep apnea and other breathing related sleep disorders.